| Dr Rohan Devanpalli-ramaya, MD | |
|
456 N New Ballas Rd Ste 348, Creve Coeur, MO 63141-6846 | |
| (314) 548-0265 | |
| (314) 548-6555 |
| Full Name | Dr Rohan Devanpalli-ramaya |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 18 Years |
| Location | 456 N New Ballas Rd Ste 348, Creve Coeur, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396057535 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 4301097325 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Louis West Dialysis | Saint louis, MO | Dialysis facility |
| Shrewsbury Dialysis | Saint louis, MO | Dialysis facility |
| Arnold Dialysis | Arnold, MO | Dialysis facility |
| Missouri Baptist Medical Center | Town and country, MO | Hospital |
| Mercy Hospital St Louis | Saint louis, MO | Hospital |
| Barnes-jewish West County Hospital | Creve coeur, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Louis Kidney Llc | 0143446617 | 8 |
News Archive
It's well known that smoking cigarettes increases risk for a host of serious health problems from cancer to heart disease. Now a new study from Weill Cornell Medical College in New York City looks at how they do their dirty work by contributing to atherosclerosis, or hardening of the arteries. The evidence points to nicotine, the addictive chemical in cigarettes.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today reported that the Company has received Frost & Sullivan's 2009 North American RNAi Therapeutic Design & Delivery Technology Innovation of the Year Award for the development of its proprietary RNAi compounds, rxRNA™, and advanced delivery approaches.
Adaptimmune Therapeutics plc, a clinical stage biopharmaceutical company focused on the use of TCR engineered T-cell therapy to treat cancer, today announced a poster presentation of data on its lead clinical program, an affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen, in both solid and hematologic cancers.
Saturated fats have a deservedly bad reputation, but Johns Hopkins scientists have discovered that a sticky lipid occurring naturally at high levels in the brain may help us memorize grandma's recipe for cinnamon buns, as well as recall how, decades ago, she served them up steaming from the oven.
The Wellcome Trust, one of the world's largest medical charities, has awarded £8.1 million over 5 years to a team of six scientists at the University of Dundee to help discover new drugs to treat some of the world's most neglected tropical diseases.
› Verified 3 days ago
| Entity Name | St Louis Kidney Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730593757 PECOS PAC ID: 0143446617 Enrollment ID: O20140725000340 |
News Archive
It's well known that smoking cigarettes increases risk for a host of serious health problems from cancer to heart disease. Now a new study from Weill Cornell Medical College in New York City looks at how they do their dirty work by contributing to atherosclerosis, or hardening of the arteries. The evidence points to nicotine, the addictive chemical in cigarettes.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today reported that the Company has received Frost & Sullivan's 2009 North American RNAi Therapeutic Design & Delivery Technology Innovation of the Year Award for the development of its proprietary RNAi compounds, rxRNA™, and advanced delivery approaches.
Adaptimmune Therapeutics plc, a clinical stage biopharmaceutical company focused on the use of TCR engineered T-cell therapy to treat cancer, today announced a poster presentation of data on its lead clinical program, an affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen, in both solid and hematologic cancers.
Saturated fats have a deservedly bad reputation, but Johns Hopkins scientists have discovered that a sticky lipid occurring naturally at high levels in the brain may help us memorize grandma's recipe for cinnamon buns, as well as recall how, decades ago, she served them up steaming from the oven.
The Wellcome Trust, one of the world's largest medical charities, has awarded £8.1 million over 5 years to a team of six scientists at the University of Dundee to help discover new drugs to treat some of the world's most neglected tropical diseases.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Rohan Devanpalli-ramaya, MD Po Box 78429, Saint Louis, MO 63178-8429 Ph: (314) 548-0265 | Dr Rohan Devanpalli-ramaya, MD 456 N New Ballas Rd Ste 348, Creve Coeur, MO 63141-6846 Ph: (314) 548-0265 |
News Archive
It's well known that smoking cigarettes increases risk for a host of serious health problems from cancer to heart disease. Now a new study from Weill Cornell Medical College in New York City looks at how they do their dirty work by contributing to atherosclerosis, or hardening of the arteries. The evidence points to nicotine, the addictive chemical in cigarettes.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today reported that the Company has received Frost & Sullivan's 2009 North American RNAi Therapeutic Design & Delivery Technology Innovation of the Year Award for the development of its proprietary RNAi compounds, rxRNA™, and advanced delivery approaches.
Adaptimmune Therapeutics plc, a clinical stage biopharmaceutical company focused on the use of TCR engineered T-cell therapy to treat cancer, today announced a poster presentation of data on its lead clinical program, an affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen, in both solid and hematologic cancers.
Saturated fats have a deservedly bad reputation, but Johns Hopkins scientists have discovered that a sticky lipid occurring naturally at high levels in the brain may help us memorize grandma's recipe for cinnamon buns, as well as recall how, decades ago, she served them up steaming from the oven.
The Wellcome Trust, one of the world's largest medical charities, has awarded £8.1 million over 5 years to a team of six scientists at the University of Dundee to help discover new drugs to treat some of the world's most neglected tropical diseases.
› Verified 3 days ago
Usman Javaid, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 11477 Olde Cabin Rd Ste 102, Creve Coeur, MO 63141 Phone: 314-432-5144 Fax: 314-432-2400 | |
Dr. Michele T Bellamy, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 12680 Olive Blvd Ste 100, Creve Coeur, MO 63141 Phone: 314-251-8900 Fax: 314-251-8901 | |
Dr. Ahmad Hassan Irshad, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 615 S New Ballas Rd, Creve Coeur, MO 63141 Phone: 314-251-6930 | |
Mikael Garri, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 621 S New Ballas Rd, Suite 3016b, Creve Coeur, MO 63141 Phone: 314-251-6339 Fax: 314-251-4564 | |
Bruce Jeffrey Lippmann, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1009 Executive Parkway Dr, Creve Coeur, MO 63141 Phone: 573-267-2318 Fax: 314-293-6811 | |
Janet Todorczuk, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 11525 Olde Cabin Rd, Creve Coeur, MO 63141 Phone: 314-997-0554 Fax: 314-997-5086 |